Plasma methoxytyramine: A novel biomarker of metastatic pheochromocytoma and paraganglioma in relation to established risk factors of tumor size, location and SDHB mutation status

BACKGROUND: There are currently no reliable biomarkers for malignant pheochromocytomas and paragangliomas (PPGLs). This study examined whether measurements of catecholamines and their metabolites might offer utility for this purpose. METHODS: Subjects included 365 patients with PPGLs, including 105...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Eisenhofer, Graeme, Lenders, Jacques W.M., Siegert, Gabriele, Bornstein, Stefan R., Friberg, Peter, Milosevic, Dragana, Mannelli, Massimo, Linehan, W. Marston, Adams, Karen, Timmers, Henri J., Pacak, Karel
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: 2011
Pynciau:
Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC3372624/
https://ncbi.nlm.nih.gov/pubmed/22036874
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ejca.2011.07.016
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg